Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Income Statement [Abstract]
REVENUES	$ 95,050	$ 10,107
COST OF REVENUES	31,204	8,572
Gross profit	63,846	1,535
OPERATING EXPENSES
Advertising	18,364	13,284
General and administrative	342,070	67,172
Legal and professional	107,740	12,965
Officer compensation	12,500	5,000
Total operating expenses	480,674	98,421
OPERATING LOSS	(416,828)	(96,886)
OTHER INCOME (EXPENSES)
Interest expense	(165,514)	(46,403)
Gain (loss) on change in derivative liability	(140,043)	(139,951)
Amortization of issuance costs	(10,246)	(97,712)
Loss on debt conversion	(32,455)
Other income	15,000
Gain on disposal of Resonate Blends	69,243
Loss on acquiition of Emergent Health Corp.	(3,007,627)
Total operating income (expense)	(3,271,642)	(284,066)
NET INCOME (LOSS)	$ (3,688,470)	$ (380,952)
INCOME (LOSS) PER SHARE- Basic	$ (0.04)	$ (0.01)
INCOME (LOSS) PER SHARE- Diluted	$ (0.04)	$ (0.01)
WEIGHTED AVERAGE SHARES OUTSTANDING, BASIC	89,983,758	75,437,604
WEIGHTED AVERAGE SHARES OUTSTANDING, DILUTED	89,983,758	75,437,604